Does Springer Nature KGaA (XTRA:SPG) Offer Value After Recent Double‑Digit Monthly Gain?

  • If you are wondering whether Springer Nature KGaA at €17.32 is priced fairly or offering hidden value, this article breaks down what the current numbers are really saying about the stock.
  • Over the last week, the share price return sits at 1.6%, with a 30 day return of 13.1%. The year to date return of 12.5% and 1 year return of 7.4% give you a wider context for how the stock has been treating investors recently.
  • Recent coverage has focused on providing investors with an evergreen view of Springer Nature KGaA, giving ongoing context rather than reacting to short term events. That kind of steady information flow can help you decide whether the latest price moves fit your own expectations for the business.
  • Right now, the company has a valuation score of 6 out of 6. The rest of this article will walk through how different valuation methods arrive at that view, before finishing with an even more practical way to think about what the current price could mean for you as an investor.

Springer Nature KGaA delivered 7.4% returns over the last year. See how this stacks up to the rest of the Media industry.

Advertisement

Approach 1: Springer Nature KGaA Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes estimates of a company’s future cash flows and discounts them back to today to arrive at an estimate of what the business might be worth right now.

For Springer Nature KGaA, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections expressed in €. The latest twelve month free cash flow is about €386.98m. Analysts provide estimates out to 2028, where free cash flow is projected at €426.87m, and Simply Wall St extrapolates further to 2035 using more modest growth assumptions.

When all those projected cash flows are discounted back and divided by the number of shares, the resulting intrinsic value per share is €58.35. Compared with the current share price of €17.32, the DCF output implies the stock is about 70.3% undervalued on this model.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Springer Nature KGaA is undervalued by 70.3%. Track this in your watchlist or portfolio, or discover 231 more high quality undervalued stocks.

SPG Discounted Cash Flow as at Apr 2026
SPG Discounted Cash Flow as at Apr 2026

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Springer Nature KGaA.

Approach 2: Springer Nature KGaA Price vs Earnings

For a profitable business like Springer Nature KGaA, the P/E ratio is a useful way to relate what you pay per share to the earnings the company is currently generating. It helps you see how much the market is paying for each €1 of earnings.

What counts as a “normal” P/E depends on how the market views the company’s growth prospects and risk. Higher expected growth or lower perceived risk often goes with a higher P/E, while lower growth or higher risk usually links to a lower P/E.

Springer Nature KGaA currently trades on a P/E of 9.68x. That sits below the Media industry average of 15.47x and also below the peer group average of 15.94x. Simply Wall St’s Fair Ratio for the company is 11.92x, which is its proprietary view of what the P/E might be given factors such as earnings growth, industry, profit margin, market cap and key risks.

The Fair Ratio can be more informative than a simple comparison with peers or the industry because it adjusts for company specific characteristics rather than assuming all media stocks deserve the same multiple. With Springer Nature KGaA at 9.68x versus a Fair Ratio of 11.92x, the shares screen as undervalued on this metric.

Result: UNDERVALUED

XTRA:SPG P/E Ratio as at Apr 2026
XTRA:SPG P/E Ratio as at Apr 2026

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 97 top founder-led companies.

Upgrade Your Decision Making: Choose your Springer Nature KGaA Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced here as simple stories you build around Springer Nature KGaA that connect your assumptions about future revenue, earnings and margins to a fair value, then compare that to the current price to help you decide whether the stock looks attractive or expensive.

On Simply Wall St’s Community page, Narratives are easy to use, available to millions of investors and continually refresh when new information such as news or earnings is added. This means your story, forecast and fair value estimate stay aligned with the latest data rather than becoming stale.

For Springer Nature KGaA, for example, one investor might lean toward the more cautious view that ties to a fair value of €22.0 with margins closer to 13.7% and earnings of €291.2m by about 2029. Another might align with the higher consensus fair value of €28.33 that assumes margins near 14.0% and earnings of €293.7m by about 2028. Each can clearly see how their chosen Narrative, and its fair value, compares to today’s share price when deciding what to do next.

Do you think there's more to the story for Springer Nature KGaA? Head over to our Community to see what others are saying!

XTRA:SPG 1-Year Stock Price Chart
XTRA:SPG 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About XTRA:SPG

Springer Nature KGaA

Engages in the publishing business in Germany, the United Kingdom, the United States, and internationally.

Very undervalued with solid track record.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0768.0% undervalued
289 users have followed this narrative
1 users have commented on this narrative
43 users have liked this narrative
GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.3% undervalued
102 users have followed this narrative
2 users have commented on this narrative
29 users have liked this narrative
TO
Tokyo
ABI logo
Tokyo on Anheuser-Busch InBev ·

EU#8 - Anheuser-Busch InBev: Courage, Capital, and the Discipline to Build an Empire

Fair Value:€89.4524.2% undervalued
9 users have followed this narrative
3 users have commented on this narrative
4 users have liked this narrative
OS
oscargarcia
AMZN logo
oscargarcia on Amazon.com ·

The capitalist colossus that makes your parcels magically appear, powers half the internet, and knows your shopping habits.

Fair Value:US$2803.2% undervalued
66 users have followed this narrative
1 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

KA
kapirey
OGC logo
kapirey on OceanaGold ·

OceanaGold: Potential Upside with High Costs and Mid-Tier Status

Fair Value:CA$65.3336.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18057.8% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
HedgeY
NWRN logo
HedgeY on Newron Pharmaceuticals ·

Still A Binary Phase III Bet on Evenamide

Fair Value:CHF 1824.4% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.3% undervalued
102 users have followed this narrative
2 users have commented on this narrative
29 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.229.5% undervalued
69 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$561.9326.1% undervalued
1400 users have followed this narrative
2 users have commented on this narrative
12 users have liked this narrative